AVITA Medical, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71.6M | $64.3M | $50.1M | $34.4M | $29.2M | $14.3M | $5.5M | $929.0K |
| Cost of Revenue | $12.8M | $9.1M | $7.8M | $6.0M | $5.9M | $3.0M | $1.3M | $546.0K |
| Gross Profit | $58.8M | $55.2M | $42.4M | $28.4M | $23.3M | $11.3M | $4.2M | $383.0K |
| Gross Margin | 82.1% | 85.8% | 84.5% | 82.4% | 79.6% | 79.2% | 76.8% | 41.2% |
| Operating Expenses | ||||||||
| Research & Development | $20.8M | $20.4M | $20.8M | $13.9M | $14.8M | $9.2M | $8.0M | $6.3M |
| SG&A Expense | $27.4M | $33.2M | $28.3M | $23.3M | $22.4M | $33.0M | $15.1M | $9.4M |
| Operating Income | $-42.5M | $-56.6M | $-42.7M | $-27.5M | $-26.5M | $-42.7M | $-25.5M | $-13.8M |
| Operating Margin | -59.4% | -88.1% | -85.1% | -79.9% | -90.8% | -299.2% | -466.4% | -1,489.9% |
| Interest Expense | $5.0M | $5.4M | $1.1M | $16.0K | $22.0K | $33.0K | $27.0K | $21.0K |
| Pretax Income | $-48.6M | $-61.8M | $-35.3M | $-26.6M | $-26.5M | $-42.0M | $-25.2M | $-13.8M |
| Income Tax Expense | $11.0K | $54.0K | $66.0K | $36.0K | $38.0K | $4.0K | $-121.0K | $-1.1M |
| Net Income | $-48.6M | $-61.8M | $-35.4M | $-26.7M | $-26.6M | $-42.0M | $-25.1M | $-12.7M |
| Net Margin | -67.8% | -96.3% | -70.6% | -77.5% | -90.9% | -294.7% | -458.6% | -1,370.8% |
| EPS (Basic) | $-1.74 | $-2.39 | $-1.40 | $1.07 | $1.17 | $2.07 | $1.56 | $1.37 |
| EPS (Diluted) | $-1.74 | $-2.39 | $-1.40 | $1.07 | $1.17 | $2.07 | $1.56 | $1.37 |
| Shares Outstanding (Basic) | 27.9M | 25.9M | 25.3M | 25.0M | 22.7M | 20.3M | 16.1M | 9.3M |
| Shares Outstanding (Diluted) | 27.9M | 25.9M | 25.3M | 25.0M | 22.7M | 20.3M | 16.1M | 9.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |